Elanix Biotechnologies develops and commercializes tissue regeneration products for chronic and acute wound care, and advanced skin care products for dermatological and gynaecological applications. Our technology is the result of 30 years of progenitor cell research and development by Prof. Lee Ann Laurent-Applegate and her team at the University Hospital of Lausanne (CHUV). The Company is headquartered in Berlin, Germany with offices in Nyon, Switzerland and Wiesbaden, Germany, and listed on the Frankfurt stock exchange under the symbol ELN.
View Top Employees from Elanix Biotechnologies SA| Website | http://www.elanixbiotechnologies.com |
| Ticker | FWB:ELN |
| Employees | 5 (3 on RocketReach) |
| Founded | 2012 |
| Address | Chemin du Joran, 10, Nyon, Vaud 1260, CH |
| Phone | +41 22 552 09 71 |
| Technologies |
JavaScript,
HTML,
StatCounter
+1 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Science and Engineering, Regenerative Medicine, Health Care, Advanced Wound Care, Life Science, Advanced Skin Care, Progenitor Cell Therapy |
Looking for a particular Elanix Biotechnologies SA employee's phone or email?
Elanix Biotechnologies SA Questions
3 people are employed at Elanix Biotechnologies SA.
Elanix Biotechnologies SA is based in Nyon, Vaud.
Top Elanix Biotechnologies SA Employees
-
55+
Related Companies
